Literature for peptidase C13.004: legumain, animal-type

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

2024
1. Zhou,L., Wu,J., Wei,Z. and Zheng,Y.
   Legumain in cardiovascular diseases
   Exp Biol Med (Maywood)249, 10121-10121. PubMed  Europe PubMed DOI  V
2023
2. Ke,B.Y., Qin,Y.S., Cheng,L. and Wang,S.Z.
   Legumain: a potential biomarker for atherosclerosis
   J Pharm Pharmacol75, 1395-1404. PubMed  Europe PubMed DOI  V
2021
3. Zhang,W. and Lin,Y.
   The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review
   Cells10, PubMed  Europe PubMed DOI  V
2020
4. Kang,S.S., Ahn,E.H. and Ye,K.
   Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease
   Exp Mol Med52, 1275-1287. PubMed  Europe PubMed DOI  V
5. Kim,N. and Lee,H.J.
   Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease
   Biomed Res Int2020, 2010728-2010728. PubMed  Europe PubMed DOI  V
6. Reddy,B.D., Beeraka,N.M., Chitturi,C.M.K. and Madhunapantula,S.V.
   An Overview on Targeting Legumain for Inhibiting Cancers
   Curr Pharm Des PubMed  Europe PubMed DOI  K  V
2019
7. Lunde,N.N., Bosnjak,T., Solberg,R. and Johansen,H.T.
   Mammalian legumain - a lysosomal cysteine protease with extracellular functions?
   Biochimie166, 77-83. PubMed  Europe PubMed DOI  V
8. Poreba,M.
   Recent advances in the development of legumain-selective chemical probes and peptide prodrugs
   Biol Chem400, 1529-1550. PubMed  Europe PubMed DOI  V  I
2016
9. Dall,E. and Brandstetter,H.
   Structure and function of legumain in health and disease
   Biochimie122, 126-150. PubMed  Europe PubMed DOI  V
2004
10. Chen,J.M., Dando,P.M. and Barrett,A.J.
    Mammalian legumain
    [ISSN:0-12-079610-4]2, 1302-1305.  V